HUMULIN R DIN 00586714
Status: Cancelled Post Market
Holder: ELI LILLY CANADA INC
Molecule: INSULIN SEMI SYNTHETIC HUMAN
Available to quote
Health Canada record
| Active ingredient(s) | INSULIN SEMI SYNTHETIC HUMAN 100 UNIT |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular; Intravenous; Subcutaneous |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | A10AB01 INSULIN (HUMAN) |
| Original market date | 31-Dec-1983 |
| Current status date | 25-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).
No Canadian shortage report is currently matched to this DIN.
Request a quote for HUMULIN R